throbber
Research
`
`Syringe Siliconization Process Investigation and Optimization
`
`EDWIN CHAN, AARON HUBBARD, SAMIR SANE, and YUH-FUN MAA*
`
`Pharmaceutical Processing and Technology Development, Genentech, a member of Roche Group ©PDA, Inc. 2012
`
`ABSTRACT: The interior barrel of the prefilled syringe is often lubricated/siliconized by the syringe supplier or at the
`syringe filling site. Syringe siliconization is a complex process demanding automation with a high degree of precision;
`this information is often deemed “know-how” and is rarely published. The purpose of this study is to give a detailed
`account of developing and optimizing a bench-top siliconization unit with nozzle diving capabilities. This unit
`comprises a liquid dispense pump unit and a nozzle integrated with a Robo-cylinder linear actuator. The amount of
`coated silicone was determined by weighing the syringe before and after siliconization, and silicone distribution was
`visually inspected by glass powder coating or characterized by glide force testing. Nozzle spray range, nozzle
`retraction speed, silicone-coated amount, and air-to-nozzle pressure were found to be the key parameters affecting
`silicone distribution uniformity. Distribution uniformity is particularly sensitive to low-target silicone amount where
`the lack of silicone coating on the barrel near the needle side often caused the syringes to fail the glide force test or
`stall when using an autoinjector. In this bench-top unit we identified optimum coating conditions for a low silicone
`dose, which were also applicable to a pilot-scale siliconization system. The pilot unit outperformed the bench-top unit
`in a tighter control (standard deviation) in coated silicone amount due to the elimination of tubing flex. Tubing flex caused
`random nozzle mis-sprays and was prominent in the bench-top unit, while the inherent design of the pilot system
`substantially limited tubing flux. In summary, this bench-top coating unit demonstrated successful siliconization of the 1
`mL long syringe with ⬃0.2 mg of silicone oil using a spraying cycle also applicable to larger-scale siliconization.
`
`KEYWORDS: Prefilled syringe, Siliconization, Dive-in nozzle spray, Silicone amount, Silicone distribution, Glide
`force, Glass powder testing
`
`LAY ABSTRACT: Syringe siliconization can be considered a well-established manufacturing process and has been
`implemented by numerous syringe providers. However, its technical details and associated critical process parameters
`are rarely published. The purpose of this study is three-fold: (1) to reveal design details of a bench-top siliconization
`unit, (2) to identify critical process parameters and determine their optimum range to provide consistent and even
`silicone coating, and (3) to demonstrate the applicability of the optimum process condition derived from the bench-top
`unit to a pilot siliconization unit. The outcomes of this study will benefit scientists and engineers developing pre-filled
`syringe products by helping them to better understanding silicone spray coating principles and their relationship to
`siliconization processes in a large-scale manufacturing setting.
`
`Introduction
`
`Pre-filled syringes are now the primary container of
`choice for most parenteral drug delivery systems,
`mainly because they are safe and user-friendly (1).
`Manufacturing a pre-filled syringe product is a com-
`plex process
`(2– 4),
`including liquid formulation
`
`* Corresponding author: Genentech, 1 DNA Way,
`South San Francisco, CA 94080. TEL: 650-225-3499.
`FAX: 650-742-1504. E-mail: maay@gene.com.
`doi: 10.5731/pdajpst.2012.00856
`
`preparation (thawing, compounding, sterile-filtration,
`etc.), component assembly (syringe, stopper, needle,
`and needle shield), syringe fill, stopper placement,
`labelling, packaging, and so on. Some device com-
`ponents are lubricated (or siliconized, as silicone
`oil
`is the industry standard and a Food and Drug
`Administration–approved lubricant), particularly the
`interior barrel of the syringe to ensure ease of syringe
`performance and consistency of the injection force
`(3–5). Siliconization can be performed by the syringe
`manufacturer in the ready-to-fill (or nest or tub) format
`or in the syringe fill facility prior to filling in the bulk
`configuration (3).
`
`136
`
`PDA Journal of Pharmaceutical Science and Technology
`
`Novartis Exhibit 2006.001
`Regeneron v. Novartis, IPR2020-01317
`
`

`

`There are three types of silicone fluid, or polydimeth-
`ylsiloxane (PDMS), available for syringe/cartridge lu-
`brication: non-reactive silicone oil (e.g., Dow Corning
`[DC] 360 Medical Fluid available in five viscosities),
`non-reactive silicone emulsion (e.g., DC 365 35%
`Dimethicone NF Emulsion), and reactive (curable)
`silicone fluid (e.g., DC MDX5-4159 Medical Grade
`Dispersion). After silicone application, a high-temper-
`ature “baking” process is required for silicone emul-
`sion and reactive silicone fluid for depyrogenation, or
`curing. The non-reactive silicone oil doesn’t require
`the post-application baking process as DC 360 are
`tested for bacterial endotoxins and certified to meet
`National Formulary/European Pharmacoepeia specifi-
`cations (6). Regardless of the silicone fluid type, sili-
`cone
`applications
`are
`commonly performed by
`wipe-on or spray coating (5), where the fluid is atom-
`ized into a mist via a nozzle and deposited on the
`coated surface. Thus, siliconization relies on three
`mechanisms: accurate dosing, controlled atomization,
`and precise nozzle movement. Two-fluid atomization
`of viscous silicone fluid via high-pressure air is cur-
`rently the best option for producing fine droplets. A
`precision pump is used to accurately deliver a minute
`amount of fluid for atomization. The nozzle needs
`to travel at a controlled speed inside the syringe
`barrel to coat its inner surface evenly. These three
`mechanisms need to coordinate perfectly to provide a
`fixed dose of fluid distributed uniformly across the
`internal surface of the syringe. Despite the fact that
`automated, high-speed manufacturing processes have
`been established for many years to produce siliconized
`syringes, our literature search failed to find publica-
`tions detailing siliconization process development. In-
`stead, most publications focused on formulation and
`stability considerations as the result of silicone-protein
`interactions (4, 7–9).
`
`The objective of this study is to develop and optimize
`a bench-top siliconization system with a focus of
`assessing the effect of critical parameters on coating
`amount and distribution uniformity. This bench-top
`unit was also compared with a semi-automated, pilot-
`scale siliconization system to understand how system
`design affects siliconization performance.
`
`Materials and Methods
`
`All experiments in this study employed 1.0 mL long
`27G 1⁄2⬙ staked needle syringes to be coated with
`silicone oil (DC 360 Medical Fluid, 1000 cSt) using a
`bench-top siliconization system (Figure 1) or a semi-
`
`automated pilot scale unit. Equipment and materials
`used in this study are tabulated in Table I.
`
`Bench-Top Siliconization System—Spraying Unit
`
`The siliconization bench-top unit was assembled and
`tested by Volo Technologies (Roseville, CA). This
`setup (Figure 1a) integrates a spraying unit with a
`robot system controlling nozzle movement. The spray-
`ing unit (Figure 1b) consists of an IVEK Sonicair
`nozzle, a piston pump, a pump linear actuator, a heater
`module, and a Digisonic controller, while the robot
`system is composed of a Robo-cylinder linear actuator
`and its controller. A high-precision, ceramic positive
`displacement pump controlled by a linear actuator for
`dosing delivers silicone oil to the Sonicair nozzle set.
`The nozzle set includes a nozzle head and a nozzle
`(enlarged section of Figure 1b). The head contains
`ports to receive silicone oil, air, and a heat cartridge.
`The nozzle itself, based on a two-fluid atomization
`mechanism, features two concentric tubes with sili-
`cone oil flowing through the inner tube and high-
`pressure air flowing between the two tubes. The oil
`and the air meet at the tip of the nozzle for mixing, and
`the mixture is sprayed via a 0.5 mm orifice into a
`cone-shaped mist (Figure 1c). Nozzle air is supplied
`via in-house compressed air and controlled by a pres-
`sure gauge. The same air source controlled by a sep-
`arate pressure gauge is fed to the silicone oil reservoir
`(5 psi was used throughout this study), which precedes
`the piston pump module. The nozzle head can be
`equipped with a heating element as an optional fea-
`ture. A heat cartridge (Firerod威, Watlow, St. Louis,
`MO), when inserted into the port on the nozzle head,
`can heat the nozzle head to a pre-set temperature (in
`the range of 25 to 125 °C). The temperature of the
`nozzle will rise due to heat transferred from the nozzle
`head. Nozzle air can be simultaneously heated by a
`heating tube inserted between the pressure gauge and
`the nozzle head and controlled by a separate heat
`controller.
`
`The pump module is a piston/cylinder arrangement
`providing positive displacement. The actuator module
`selectively rotates and reciprocates the ceramic piston
`via a coupling at one end, and the piston incorporates
`a slit that provides a valving function at the other end.
`Initially the piston flat aligns with the silicone oil
`intake port and then retracts to fill the cylinder with
`liquid. The piston rotates 180° with the flat facing the
`discharge port and then pushes forward to force the
`
`Vol. 66, No. 2, March–April 2012
`
`137
`
`Novartis Exhibit 2006.002
`Regeneron v. Novartis, IPR2020-01317
`
`

`

`TABLE I
`Equipment and Materials Used in the Study
`
`Equipment
`
`Balance
`
`Two fluid nozzle (5 mm OD and 90 mm length)
`
`Ceramic positive displacement piston pump and
`controller
`
`Pump controller module (Micro linear actuator)
`
`Robo-cylinder linear actuator
`PLC/HMI controller
`Nozzle heater
`Nozzle heater controller
`
`Instron force measuring device
`Vent wire stoppering tool
`
`Semi-automatic syringe washer
`
`Materials
`1 mL-Long syringe with 27G ⫻ 1⁄2⬙ staked needle
`
`Tefzel tubing (1/8⬙ OD, 1/16⬙ ID)
`Plunger stopper
`
`Polystyrene plunger rod
`
`Silicone fluid
`
`Supplier/Model
`
`Mettler Toledo AG 204 (Columbus,
`OH)/AG135
`IVEK Corp. (North Springfield,
`Vermont)/Sonicair
`IVEK Corp. (North Springfield,
`Vermont)/Micro linear pump
`module & Linear actuator module
`IVEK Corp. (North Springfield,
`Vermont)/Digispense 3020
`IAI America (Torrence, CA)
`Omron American (Schaumburg, IL)
`Watlow (St. Louis, MO)/Firerod威
`Red Lion Controls (York, PA)/Model
`T48
`Instron (Grove City, PA)/Model 5542
`Becton Dickinson (Franklin Lakes,
`NJ)/Custom tool
`Bausch Advanced Technology
`(Clinton, CT) Type 303 Washer
`Supplier/Model
`Becton Dickinson (Swedesboro, NJ)/
`Hypak Type 1 glass syringes (Lot #
`082111)
`Upchurch Scientic (Oak Harbor, WA)
`West Pharmaceuticals (Lionville, PA)
`W4023/FLT (Lot # 0000122330)
`Becton Dickinson (Bridgeport, NJ)/
`Plunger rod for 1mL Long (Lot #
`44386)
`Dow Corning (Midland, MI)/Dow 360
`Medical Fluid, 1,000 cSt (Lot #
`0005938393)
`
`required amount of oil through the discharge port.
`The piston rotates 180° again back to the initial posi-
`tion to complete the dispense cycle. The height that
`the piston travels determines the volume of the oil to
`be sprayed.
`
`Robotic Movement Control
`
`The Robo-cylinder linear actuator provides the diving
`action for the nozzle set (Figure 1a & b). The whole
`nozzle set moves up and down per the commands from
`the Volo Controller. This controller combines the
`function of a programmable logic controller (PLC) and
`
`a human machine interface (HMI). The siliconization
`bench-top unit can be run manually or programmed to
`run an automatic siliconization cycle where the nozzle
`dives upward into the syringe and sprays silicone
`while retracting. The Volo Controller is interfaced
`with the Digispense Controller to send signals to begin
`and end pumping the oil. To enable the function of
`controlling nozzle movement such as the dive-in po-
`sition, the spray position, the spray rate, and the ac-
`celeration/deceleration, various setpoints need to be
`entered on Volo HMI and Digispense. The procedure
`of preparing a worksheet for setpoint entry is detailed
`in the Appendix.
`
`138
`
`PDA Journal of Pharmaceutical Science and Technology
`
`Novartis Exhibit 2006.003
`Regeneron v. Novartis, IPR2020-01317
`
`

`

`Figure 1
`
`(a) The entire bench-top siliconization system; (b) detailed representation of the pump module, the nozzle set,
`and syringe fixture and station; (c) detailed graphic representation of the nozzle design and the two-fluid
`atomization mechanism; and (d) syringe fixture station without the extension.
`
`Pilot-Scale Siliconization Station
`
`The semi-automated syringe washing/siliconization
`equipment was designed and assembled by Bausch
`
`Advanced Technology (Clinton, CT). This pilot-scale
`equipment is equipped with an Allen Bradley touch
`screen HMI that provides operators with full control of
`machine settings to wash, air-dry, and siliconize sy-
`
`Vol. 66, No. 2, March–April 2012
`
`139
`
`Novartis Exhibit 2006.004
`Regeneron v. Novartis, IPR2020-01317
`
`

`

`ringes. Syringes are fed manually at the in-feed station
`with needle pointing downward. The in-feed scroll
`indexes and transports the syringes into individual
`grippers. The gripper then rotates and inverts the sy-
`ringe 180°, with needle pointing upward. The syringe
`is then transported through 16 gripper stations that
`include three washing stations, five drying stations,
`one barrel siliconization station, and one needle sili-
`conization station (a feature not relevant to this study).
`The mechanism of siliconization is very similar to the
`bench-top silicone oil spraying unit described above.
`
`Both pilot-scale and bench-top units utilize the same
`IVEK Sonicair spraying nozzle combined with a high-
`precision, ceramic positive displacement pump and
`heating elements. Customized setpoints, such as sili-
`cone dosing amount, nozzle/air
`temperatures, and
`spray nozzle movement/positions can be controlled
`via the washer HMI. A dive-in siliconization motion is
`achieved by the use of a cam fixture, which works
`similarly to the linear actuator in the bench-top unit.
`However, the pilot-scale siliconization station features
`a synchronized movement of the pump and the nozzle,
`as both are physically attached to the cam fixture. This
`feature enhances siliconization performance and will
`be discussed in the Discussion Section.
`
`Silicone Amount
`
`The amount of silicone oil applied on each syringe was
`determined by using a high-precision digital balance
`(Mettler Toledo AG 204). Empty syringes were
`weighed before and after the siliconization process.
`The silicone oil quantities were measured by calculat-
`ing the differences between the two values.
`
`Fixed Nozzle Siliconization Testing
`
`Syringes (n ⫽ 5) were sprayed with 0.5 mg of silicone
`oil using an air-to-nozzle pressure of 15 psi at three
`fixed positions, 5 mm, 20 mm, and 35 mm past the
`flange. Each siliconized syringe was then coated with
`glass powder and visually inspected.
`
`Silicone Distribution (Glass Powder Method)
`
`⫽
`A Schott glass powder 8250 (Grain Size K1, d50
`30 ␮m ⫾ 10 ␮m, d99
`ⱕ 150 ␮m) was used to visualize
`and assess silicone distribution uniformity in the inner
`barrel of a syringe. This specific glass powder was
`designed to only stick to glass surfaces coated with
`silicone oil. Approximately 150 mg of glass powder
`
`was poured into the open end of the syringe, which
`was subsequently covered with parafilm. The syringe
`was then tilted, tapped, and shaken manually for 30 s
`while in a horizontal position to distribute powder
`along the axis of the barrel. Subsequently, the used
`powder was discarded. With the open end pointing
`downward, the syringe was tapped gently against a flat
`surface for up to 25 times to remove any excess
`powder. Coated syringes were then inspected visually
`for homogeneous powder distribution. Any empty gap
`greater than 5 mm was defined as unacceptable.
`
`Silicone Distribution (Glide Force Method)
`
`High-speed force testing was performed as a quanti-
`tative assay to gauge silicone distribution uniformity
`within the inner barrel of the syringe. A plunger stop-
`per
`(W4023/FLT, West Pharmaceutical, Lionville,
`PA) was inserted into the empty, post-siliconized sy-
`ringe approximately 8 mm inward (measured from the
`back of the syringe flange to the back of a stopper)
`using a vent wire stoppering tool (Becton Dickinson,
`Franklin Lakes, NJ). Next, a polystyrene plunger rod
`was carefully threaded into the plunger stopper. A
`material testing system (model 5542, Instron, Grove
`City, PA) with a load cell was used to apply a steady
`compression rate, and the gliding force profile was
`then analyzed for silicone coating consistency and
`variation per an internal protocol.
`
`Results and Discussion
`
`Two coating experiments were initially performed to
`confirm the effect of fixed-position spray coating on
`distribution uniformity and coated silicone amount.
`The experimental set-up follows Figure 1d, where the
`syringe fixture extension was not used.
`
`Effect of Fixed-Position Spray on Coating Distribution
`Uniformity
`
`Figure 2a– c shows distribution uniformity results for
`the fixed-position spray coating at 5, 20, and 35 mm
`past the flange, respectively. Spraying near the flange
`(5 mm) resulted in silicone deposition mostly on the
`flange side of the barrel and leaving the barrel on the
`needle side uncoated. When the nozzle was deeper
`into the syringe (20 mm), the middle section of the
`barrel was coated. Further into the syringe at 35 mm
`past the flange, coating occurred primarily at the nee-
`dle side. This finding suggests that fixed-position
`spray yields uneven distribution and that the nozzle
`
`140
`
`PDA Journal of Pharmaceutical Science and Technology
`
`Novartis Exhibit 2006.005
`Regeneron v. Novartis, IPR2020-01317
`
`

`

`Figure 2
`
`Glass powder testing on syringes coated with 0.5 mg of silicone oil at three fixed positions, (a) 5 mm, (b) 20 mm,
`and (c) 35 mm past the flange, using 5 psi air-to-nozzle pressure.
`
`needs to spray and retract simultaneously. Spraying
`over the range of 5–35 mm past the flange along with
`nozzle movements may result in uniform coating over
`the entire barrel. This will be studied using the pilot-
`scale system and results will be discussed later.
`
`Effect of Spraying Nozzle Position, Nozzle Pressure,
`and Spray Rates on Coating Amount
`
`The design of this experiment involved the variation
`of three process parameters—three nozzle spraying
`positions (10, 27, and 44 mm past the flange), two
`air-to-nozzle pressures (5 and 15 psi), and three spray
`rates (0.420, 4.316, and 8.210 mg/s). The selection of
`these spray rates was intended to cover a wide nozzle
`movement range, that is, deep dive with slow retrac-
`tion and shallow dive with quick retraction. A full
`factorial experimental design set with these variables
`gives 18 sets of conditions, that is, a total of 180 sam-
`ples at n ⫽ 10. The target dose is 0.3 mg silicone for
`all conditions.
`
`The results for coated silicone amount (Figure 3)
`reveal an obvious problem: a significant number of
`under-coated samples (⬍0.1 mg), including no coating
`(zero silicone-coated). It appears that the siliconiza-
`tion bench-top unit occasionally mis-sprayed, or
`
`sprayed prematurely. As the nozzle dived in and out of
`the syringe, it pinched the Teflon tubing between the
`pump and the nozzle to flex. The flexing movement
`could squeeze a minute amount of silicone oil out of
`the nozzle and spray out of the cycle (not inside the
`syringe). When the tubing returned to a relaxed posi-
`tion, the silicone level retracted and left a void volume
`at the nozzle tip. Thus, the syringe in the next spraying
`cycle would be undercoated. The mis-spray problem
`confounded the data and allowed for few conclusions
`to be drawn. This problem occurred randomly and
`needed to be resolved or minimized before other ex-
`periments could be performed.
`
`Approaches to Resolve Mis-Spray/Premature Spray
`Issues due to Tubing Flex
`
`A straightforward approach is to shorten the distance
`that nozzle travels as well as the length of tubing
`between the pump and the nozzle. To test this concept,
`an extension (95 mm) was inserted at the top of the
`syringe fixture (Figure 1d) to minimize the distance
`that the nozzle travels (only inside the syringe), and
`the tubing length was reduced to only loosely hang in
`the air. This setup was used to spray 0.3 mg of silicone
`during nozzle retraction over the range of 30 to 10 mm
`past the flange. Two parameters were varied at three
`
`Vol. 66, No. 2, March–April 2012
`
`141
`
`Novartis Exhibit 2006.006
`Regeneron v. Novartis, IPR2020-01317
`
`

`

`Figure 3
`
`Result summary of coated silicone amount for syringes coated at three fixed positions (10, 27, and 44 mm past
`the flange), two air-to-nozzle air pressures (5 and 15 psi), and three spray rates (0.420, 4.316, and 8.210 ␮L/s)
`with a target silicone dose of 0.3 mg.
`
`levels, air-to-nozzle pressure (5, 10, and 15 psi) and
`retraction speed (50, 100, and 150 mm/s). Thus, this
`study involved nine conditions (n ⫽ 10) with a total
`sample size of 90 syringes.
`
`The silicone amount results in Figure 4 show a great
`improvement in repeatability of the silicone dose, with
`
`Figure 4
`
`Result summary of coated silicone amount with a
`modified experimental setup using a syringe exten-
`sion (95 mm) and a shortest tubing length (⬃25 cm).
`Syringes were coated with a moving nozzle that dived
`in 40 mm past the flange and sprayed across the
`range of 30 –10 mm past the flange during retraction
`using three air-to-nozzle pressures (5, 10, and 15 psi)
`and retraction speeds (50, 100, and 150 mm/s) with a
`target silicone dose of 0.3 mg.
`
`only two samples coated with ⬍0.1 mg silicone, in-
`cluding one with zero coating (5 psi/100 mm/s). This
`suggests that tubing flex was much reduced but not
`completely eliminated. Overall,
`the average coated
`silicone weight is less than the target dose (0.3 mg) for
`most of the conditions, suggesting that some silicone
`droplets may be lost to depositing on the nozzle and/or
`being blown out of the syringe. The effect of the
`air-to-nozzle pressure and the retraction rate on sili-
`cone loss is not clear from this study. Conceptually,
`faster retraction may result in greater silicone loss
`(less coating) because the downward movement of the
`nozzle can offset the upward velocity of the spray so
`that some droplets may flow with air out of the syringe
`instead of depositing on the barrel.
`
`There are other approaches that may be able to com-
`pletely eliminate the tubing flex issue. One is to mo-
`bilize the nozzle and the pump (including the tubing in
`between) as one unit. Unfortunately, the linear actua-
`tor in the current setup was not capable of carrying the
`weight of the pump module. However, the pilot-scale
`siliconization unit had such a feature (Figure 8) and
`was tested as discussed later.
`
`Another approach is to keep the nozzle stationary but
`to move the syringe instead. The nozzle still sprays
`upwards but stays motionless during syringe fixture
`movement. With both nozzle and pump being motion-
`less, there should be no tubing flex. However, this
`approach is not within the scope of this investigation
`and will present a different configuration to the pilot
`unit to be evaluated later.
`
`142
`
`PDA Journal of Pharmaceutical Science and Technology
`
`Novartis Exhibit 2006.007
`Regeneron v. Novartis, IPR2020-01317
`
`

`

`Figure 5
`
`Glass powder testing and Instron glide force profile for syringes coated with 0.2 mg silicone and sprayed in
`range of 10 to 44 mm past the flange using 15 psi air-to-nozzle pressure at the retraction rate of (a) 200 mm/s
`or (b) 50 mm/s (for the three syringes on the left).
`
`Finding Key Process Parameters on Coating
`Uniformity
`
`As determined earlier, for silicone droplets to be
`evenly distributed across the whole barrel surface, the
`spraying nozzle has to dive in the syringe and spray
`during retraction. Proper siliconization at the needle
`side of the barrel is important. For spring-based auto-
`injection devices, the most severe challenge will be at
`end of the stroke, when the available spring energy
`will be at its lowest level (11). To reach this area, the
`nozzle has to dive in the syringe barrel deep enough or
`spray silicone oil droplets far enough to cover the
`needle side. The upward velocity of the droplets is
`dictated by the change in air-to-nozzle pressure but
`
`can be offset by nozzle retraction velocity and gravity.
`Therefore,
`to evaluate the effect of changing the
`spraying process on silicone distribution, four process
`parameters were varied: nozzle retraction rate (50 or
`200 mm/s), nozzle spray range (22–10 or 44 –10 mm
`past the flange), air pressure to the nozzle (5 or 15 psi),
`and target silicone quantity (0.2, 0.5, or 1.0 mg).
`Please note that nozzle retraction rate is important for
`production speed. A normal production-speed sili-
`conization spray should be under 1 s per cycle and
`50 mm/s is near that mark, depending on dive-in
`depth. Samples created for this test are listed in Table
`II with n ⫽ 10, where three samples were used for
`glass powder testing and three for Instron glide force
`testing. The glide force testing results are also sum-
`
`Vol. 66, No. 2, March–April 2012
`
`143
`
`Novartis Exhibit 2006.008
`Regeneron v. Novartis, IPR2020-01317
`
`

`

`TABLE II
`Study Design for Silicone Distribution Test (n ⴝ 10 Total Produced; n ⴝ 3 Used for Glass Powder Testing,
`and n ⴝ 3 Used for Instron Glide Force Testing)
`
`Air
`Pressure
`(psi)
`
`Speed
`(mm/s)
`
`Si
`Quantity
`(mg)
`
`Position
`(mm)
`
`# Passing
`on
`Instron
`Test
`
`15
`5
`15
`15
`5
`15
`15
`15
`15
`5
`5
`15
`15
`5
`15
`5
`5
`5
`5
`15
`5
`5
`5
`15
`
`50
`200
`200
`200
`50
`50
`200
`200
`50
`50
`200
`200
`50
`200
`50
`50
`50
`200
`50
`50
`200
`200
`50
`200
`
`0.5
`0.2
`0.5
`0.2
`0.2
`0.5
`1.0
`0.5
`0.2
`0.2
`1.0
`1.0
`0.2
`0.2
`1.0
`0.5
`1.0
`0.5
`1.0
`1.0
`0.5
`1.0
`0.5
`0.2
`
`22
`44
`44
`44
`22
`44
`22
`22
`22
`44
`44
`44
`44
`22
`22
`44
`22
`22
`44
`44
`44
`22
`22
`22
`
`3
`1
`1
`0
`1
`3
`3
`0
`1
`1
`3
`3
`3
`0
`3
`3
`3
`0
`3
`3
`1
`3
`3
`0
`
`Pattern
`⫹⫺2⫺
`⫺⫹1⫹
`⫹⫹2⫹
`⫹⫹1⫹
`⫺⫺1⫺
`⫹⫺2⫹
`⫹⫹3⫺
`⫹⫹2⫺
`⫹⫺1⫺
`⫺⫺1⫹
`⫺⫹3⫹
`⫹⫹3⫹
`⫹⫺1⫹
`⫺⫹1⫺
`⫹⫺3⫺
`⫺⫺2⫹
`⫺⫺3⫺
`⫺⫹2⫺
`⫺⫺3⫹
`⫹⫺3⫹
`⫺⫹2⫹
`⫺⫹3⫺
`⫺⫺2⫺
`⫹⫹1⫺
`
`marized in Table II, where the number of passing
`samples is listed out of three. Several observations can
`be drawn from these results.
`
`I. Nozzle Retraction Speed: Nozzle retraction rate
`plays an important role for distribution uniformity; the
`faster the retraction, the less uniform the coating. For
`example, glass powder testing for syringes coated with
`0.2 mg silicone and sprayed in range of 10 – 44 mm
`past
`the flange using 15 psi air-to-nozzle pressure
`shows less uniform coating at the retraction rate of
`50 mm/s (Figure 5a) than 200 mm/s (Figure 5b). Fast
`downward retraction offsets droplet velocity so that
`the droplets failed to reach the needle-end of the barrel
`despite a deep dive. This visual observation was con-
`firmed by the glide force measurement. All three sy-
`
`ringes coated at the 50 mm/s retraction rate show a
`constantly low glide force (⬍2 N) over the barrel
`length of 0 –38 mm (Figure 5a). At the high retraction
`rate (200 mm/s) all three syringes display an increas-
`ing glide force profile, initially below 2 N (between
`0 to 15 mm) and escalating dramatically for the rest of
`the barrel (Figure 5b), indicating the lack of lubrica-
`tion on the barrel near the needle.
`
`II. Nozzle Spraying Range: Intuitively, the move-
`ment and coverage range of nozzle spray within the
`barrel are critical to uniform distribution. The range
`should be wide to cover both ends of the barrel.
`However, a wide spraying range means that the nozzle
`has to travel a longer distance, which will prolong the
`cycle time. Therefore, to balance distribution unifor-
`
`144
`
`PDA Journal of Pharmaceutical Science and Technology
`
`Novartis Exhibit 2006.009
`Regeneron v. Novartis, IPR2020-01317
`
`

`

`cantly lower than the air pressure set by the pressure
`gauge due to pressure drop along the path between the
`pressure gauge and the orifice. The true pressure at the
`orifice is difficult to measure or predict. Another effect
`of air-to-nozzle pressure is on the size of silicone
`droplets; on the same photo it appears that 15 psi
`produced smaller droplets than 5 psi, which facilitated
`more even distribution of silicone coating.
`
`IV. Coated Silicone Amount: There is a clear trend
`that, regardless of the spraying condition, the higher
`the amount of coated silicone, the easier the syringe
`passes the glide force test. In a worst-case scenario
`where the siliconization parameters involved the high-
`est retraction rate (200 mm/s) and a shallow spray
`range (22–10 mm past the flange), and a low air-to-
`nozzle pressure (5 psi), syringes did not pass the glide
`force test until the coated amount reached 1.0 mg. It
`can be envisioned that even though silicone distribu-
`tion is not uniform (the lack of coating near the
`syringe end), the excessive silicone from the high-
`silicone-amount group may be pushed by the plunger
`rod during injection toward the needle side of the
`barrel. Despite this advantage, using a high amount of
`silicone is not desirable for biopharmaceutical prod-
`ucts where excessive silicone may be incompatible
`with the protein and jeopardize product quality (7–9)
`due to visible/sub-visible silicone particle formation
`(4, 10). The preferred silicone amount for the 1 mL
`long syringe is in the range of 0.2 to 0.5 mg per
`syringe (internal standard).
`
`Optimization Considerations
`
`The parameter investigation above was used to support
`the selection of optimum siliconization conditions. In
`the optimization test, we targeted a 0.3 mg silicone
`coating dose, which is near the low range of the
`preferred silicone amount. The selection of nozzle
`retraction rate was based on two criteria: (1) the re-
`traction rate should be as fast as possible to shorten the
`coating cycle and increase production speed, and
`(2) the retraction rate should not be too fast to com-
`promise distribution uniformity. Thus, the nozzle re-
`traction of 100 mm/s was chosen from the range of
`50 to 200 mm/s. Ideally, slow and long spray range
`should promote distribution uniformity. Since previ-
`ously the spray range of 44 to 10 mm past the flange
`displayed acceptable distribution uniformity, we tight-
`ened the nozzle spray range to 35–10 mm past the
`flange to further benefit cycle time reduction. For
`air-to-nozzle pressure, 10 psi represents the mid-point
`
`Figure 6
`
`Glass powder testing on syringes coated using the
`condition of 22–10 mm spraying range, 50 mm/s
`retraction rate, and 0.2 mg target silicone amount
`with two air-to-nozzle pressures, 15 psi (three sy-
`ringes on the right) and 5 psi (three syringes on the
`left).
`
`mity and cycle time, the nozzle spraying range and
`nozzle retraction rate should be considered at the same
`time. For example, for syringes coated using the noz-
`zle spraying range of 44 –10 mm or 22–10 mm past the
`flange (other coating parameters: 0.5 mg target sili-
`cone quantity, 15 psi air-to-nozzle pressure, 200 mm/s
`retraction rate), syringes with the deeper spraying
`range successfully passed glide force testing while
`syringes with the shallow spraying range failed the
`test. Therefore, with the fastest retraction rate, a pre-
`ferred position to begin spraying should be between
`22 mm and 44 mm past the flange. Ending spraying at
`10 mm past the flange appears to be acceptable.
`
`III. Air-to-Nozzle Pressure: By the law of conser-
`vation of energy, higher nozzle pressure can disperse
`droplets faster and farther. In Figure 6 for glass pow-
`der testing, despite the significant pressure difference,
`silicone coating is only marginally deeper using 15 psi
`air-to-nozzle pressure (three syringes on the right)
`than 5 psi (three syringes on the left). These syringes
`were coated under the condition of 22–10 mm spray-
`ing range, 50 mm/s retraction rate, and 0.2 mg target
`silicone amount. It should be noted that the air pres-
`sure coming out of the nozzle orifice may be signifi-
`
`Vol. 66, No. 2, March–April 2012
`
`145
`
`Novartis Exhibit 2006.010
`Regeneron v. Novartis, IPR2020-01317
`
`

`

`Figure 7
`
`Glass powder distribution of (a) syringes coated under the optimum condition (0.3 mg target silicone amount,
`100 mm/s nozzle retraction rate, 10 psi air-to-nozzle pressure, and 35–10 mm past the flange for the spraying
`range) and glide force testing of (b) five syringes above and of (c) another set of five syringes coated under the
`same optimum condition but with heating at 85 °C.
`
`of the tested range (5–15 psi) and appears to be
`appropriate because 5 psi might be too low to generate
`small droplets and 15 psi might be so high that it might
`disturb droplet flow for smooth deposition. In addi-
`tion, to further improve the atomization condition to
`produce finer droplets without using higher air-to-
`nozzle pressure, silicone was heated to a higher tem-
`
`perature, in the range of 85–100 °C (see Figure 1b for
`the heating mechanism) to reduce viscosity prior to
`atomization.
`
`Five syringes coated under the optimum condition
`were tested by the glass powder meth

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket